Congratulations to Patrice, laureate of the ATIP-Avenir 2019 program. This program will allow Patrice to develop new antibiotic strategies against Gram-negative bacteria like Pseudomonas aeruginosa, by coupling natural bacteriocins and synthetic toxins.
The ATIP-Avenir program (CNRS-INSERM) allows young researchers to set up and lead a team, promotes mobility and attracts young high-level team leaders to French laboratories. The annual amount allocated for operations is 60,000€, with a three-year fixed-term contract for non-statutory recipients and 2 years funding of a post-doctoral associate.
References :
https://www.insb.cnrs.fr/fr/atip-avenir
